Dr. David Maloney

For the Media

Dr. David Maloney

Dr. David Maloney is a member of Fred Hutch's Clinical Research Division and a member of the Lymphoma Program. His laboratory and clinical research is focused on the development of  development of new, safe and effective therapies for patients with lymphoid cancers, including lymphomas, leukemias and myeloma. His primary focus is treatments that can enhance anti-cancer immune responses, collectively known as immunotherapies. One strategy uses immune cell products known as antibodies.

Resources for more information

  • Overview of David Maloney's Research
    Dr. Maloney is recognized as an expert in the treatment of lymphoma, myeloma and CLL, including antibody-based treatments, reduced-intensity allogeneic HCT for NHL, CLL and myeloma patients and autologous HCT for lymphoma and myeloma patients.
  • David Maloney – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • Featured Researcher Profile
    Maloney's work focuses on developing and improving cancer therapies that take advantage of antibodies—proteins formed in our blood to fight invaders. This approach falls into a class of treatments known as immunotherapy, which harnesses the power of the body's immune system to fight disease.
  • Clinical Research Division
    Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Graphics / Video

Download

Download photos and view video of David Maloney.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.